A Phase 1b, Proof of Concept, Dose-Ranging Study to Evaluate the Safety of the Coadministration of Ascending Doses of ANS-6637 and Ethanol in Healthy Male Moderate Drinkers
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2017
At a glance
- Drugs GS 6637 (Primary)
- Indications Alcoholism; Drug abuse
- Focus Adverse reactions; Proof of concept
- Sponsors Amygdala Neurosciences
- 18 Oct 2017 According to an Altasciences media release, Altasciences are working with Amygdala Neurosciences to conduct this trial.
- 27 Jul 2017 Status changed from not yet recruiting to recruiting.
- 03 Jul 2017 New trial record